, Singapore

Healthcare startup Biofourmis raises $35m in series B round

The proceeds will be used to enhance its AI digital therapeutics platform.

Singapore-based healthtech startup Biofourmis has raised $35m in a series B round led by Sequoia India and MassMutual Ventures SEA to enhance its proprietary AI-powered digital therapeutics platform.

Also read: Here's why Singapore's healthtech landscape looks promising

The startup is also seeking to relocate its headquarters from Singapore to Boston where it will expand its commercialisation efforts. By the end of 2019, the company aims to grow to more than 100 employees in the United States and Singapore.

"Our new funds will allow us to rapidly expand our workforce and commercialisation efforts, whilst further demonstrating the clinical efficacy of our digital therapeutics platform through research and development," Kuldeep Singh Rajput, founder and CEO of Biofourmis said in a statement.  

Established in 2015, Biofourmis combines AI, therapeutic interventions, a patient-facing companion app, and wearable biosensors to provide users with actionable and personalised healthcare insights which is used in tandem with prescription software Biovitals. The bionsensors remotely monitor and analyse physilogical signals, the AI-powered technology can help predict adverse medical events and patients can easily adhere to the care plan through the smartphone app. 

Singapore government-linked strategic investor EDBI, Chinese online healthcare platform Jianke also participated in the round, and existing investors like Openspace Ventures, Aviva Ventures and SGInnovate participated in Biofourmis' funding round. 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.